Bispecific antibodies in cancer immunotherapy
![](https://i.ytimg.com/vi/QErZq3DByK0/mqdefault.jpg)
1:08:32
Treating Lymphoma with Bispecific Antibodies | LRF Webinars
![](https://i.ytimg.com/vi/K09xzIQ8zsg/mqdefault.jpg)
5:03
Tumour immunology and immunotherapy
![](https://i.ytimg.com/vi/j8Zmm8djDFA/mqdefault.jpg)
4:45
Bispecifics Part 2: Monoclonal and Bispecific Antibodies
![](https://i.ytimg.com/vi/JLkC00ZM1Rg/mqdefault.jpg)
53:53
The Latest in Immunotherapy to Treat Cancer
![](https://i.ytimg.com/vi/PUhgepIHo-M/mqdefault.jpg)
4:15
Bispecific antibodies in multiple myeloma: teclistamab, talquetamab, and cevostamab
![](https://i.ytimg.com/vi/fpAKSTT7hAE/mqdefault.jpg)
23:03
More Young People Are Getting Cancer: What's Being Done? | CNA Correspondent
![](https://i.ytimg.com/vi/x6a4hMyiwBo/mqdefault.jpg)
13:49
So, I've got cancer
![](https://i.ytimg.com/vi/-mYYMcdb_Gs/mqdefault.jpg)
6:43